H7N9 Bird Flu Virus - Biotech, Pharma and Life Science Channel

15:52 EDT 19th September 2014 | BioPortfolio

Avian influenza A H7 viruses are a group of influenza viruses that normally circulate among birds. The avian influenza A(H7N9) virus is one subgroup among the larger group of H7 viruses. Although some H7 viruses (H7N2, H7N3 and H7N7) have occasionally been found to infect humans, no human infections with H7N9 viruses have been reported until recent reports from China.

News Articles [9 Associated News Articles listed on BioPortfolio]

New York Blood Center's Laboratory of Viral Immunology Gets Support for Developing Vaccines and Therapeutics Against Emerging Viruses

NEW YORK, Sept. 18, 2014 /PRNewswire-USNewswire/ -- NYBC's Laboratory of Viral Immunology has received a National Institutes of Health (NIH) grant to develop a mucosal universal influenza vaccine....

Hemispherx' Drug Ampligen Plus Intranasal Seasonal Influenza Vaccine Induces Cross-Reactive Antibody Formation Against Avian H5N1 and H7N9 Influenza HA in Humans

PHILADELPHIA, Sept. 15, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today a peer-reviewed publication entitled "Intranasal Seasonal I...

InDevR Wins Barda Contract for Cutting-Edge Influenza Diagnostic

BOULDER, CO--(Marketwired - September 15, 2014) - InDevR, a Boulder-based life science company, announced today that it has signed a contract (HHSO100201400010C) with the Biomedical Advanced Research ...

Ansun BioPharma Announces Late Breaker Oral Presentation at ICAAC on the Clinical Activity of ParaDase™, an Investigational Drug for the Treatment of Severe Parainfluenza Infection

Ansun BioPharma announced today a late breaker oral presentation titled “DAS181 for the Treatment of Parainfluenza Virus Infections in 16 Hematopoietic Stem Cell Transplant Reci...

Avian influenza virus isolated in harbor seals poses a threat to humans

MEMPHIS, Tenn., Sept. 4, 2014 /PRNewswire-USNewswire/ -- A study led by St. Jude Children's Research Hospital scientists found the avian influenza A H3N8 virus that killed harbor seals along the New E...

Pandemic Influenza - Pipeline Review, H2 2014

Recently added to the BioPortfolio report store, Pandemic Influenza - Pipeline Review, H2 2014 is a new report from Global Markets Direct published on 2014-07-30. This 146-page report is available in...

NAS911 Being Evaluated as Co-Therapeutic for Treatment of Influenza

SCOTTSDALE, AZ -- (Marketwired) -- 08/06/14 -- New Amsterdam Sciences (NAS), an emerging bioscience company focused on treating respiratory illnesses, announced today the completion of initial confir...

InDevR Awarded $2.9 M to Advance Titer on Chip(R) for Pandemic Flu Vaccines

BOULDER, CO--(Marketwired - July 22, 2014) - InDevR, a Boulder-based life science company, announced today that it has received an SBIR Phase II grant from the National Institute of Allergy and Infect...

Arbor Vita Corporation's A/H7N9 Influenza Rapid Detection Test Authorized for Emergency Use by FDA

FREMONT, Calif., April 30, 2014 /PRNewswire-iReach/ -- A new strain of the avian influenza virus appeared in China in 2013.  This particular 'bird flu', influenza A/H7N9 virus (detected in China...

Events [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Ansun BioPharma

Ansun BioPharma is a clinical stage biopharmaceutical company focused on the development of unique host-directed anti-viral therapies for respiratory viruses. Ansun BioPharma has ...

Clinical Trials [0 Results]

None

PubMed Articles [70 Associated PubMed Articles listed on BioPortfolio]

Avian Influenza A H7N9 Virus Induces Severe Pneumonia in Mice without Prior Adaptation and Responds to a Combination of Zanamivir and COX-2 Inhibitor.

Human infection caused by the avian influenza A H7N9 virus has a case-fatality rate of over 30%. Systematic study of the pathogenesis of avian H7N9 isolate and effective therapeutic strategies are nee...

Identification, Synthesis, and Evaluation of New Neuraminidase Inhibitors.

High-throughput screening was performed on ∼6800 compounds to identify KR-72039 as an inhibitor of H1N1 and H5N1 neuraminidases (NAs). Structure-activity relationship studies led to 3e, which inhibi...

Entry Properties and Entry Inhibitors of a Human H7N9 Influenza Virus.

The recently identified human infections with a novel avian influenza H7N9 virus in China raise important questions regarding possible risk to humans. However, the entry properties and tropism of this...

Detection of Avian Influenza A(H7N9) Virus from Live Poultry Markets in Guangzhou, China: A Surveillance Report.

A virologic surveillance program for A(H7N9) virus was conducted from April 15, 2013 to February 14, 2014 in Guangzhou, aiming to clarify the geographical distribution of A(H7N9) viruses among live po...

Protection against influenza H7N9 virus challenge with a recombinant NP-M1-HSP60 protein vaccine construct in BALB/c mice.

A novel influenza virus of H7N9 subtype circulated throughout China in 2013. The high fatality rate, appearance of several family clusters, and transmission in animal models observed during this outbr...

Rapid Production of Synthetic Influenza Vaccines.

The strain composition of influenza vaccines must be changed regularly to track influenza virus antigenic evolution. During outbreaks with pandemic potential, strain changes are urgent. The systems fo...

Mammalian Models for the Study of H7 Virus Pathogenesis and Transmission.

Mammalian models, most notably the mouse and ferret, have been instrumental in the assessment of avian influenza virus pathogenicity and transmissibility, and have been used widely to characterize the...

Cross-protective efficacy of Baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.

The outbreak of human infections with avian-origin H7N9 influenza has raised global concerns about a potential human pandemic. Therefore, the generation of simple and reliable newer vaccines is high p...

Early Public Response to Influenza A(H7N9) Virus, Guangzhou, China, May 30-June 7, 2013.

Genotype Diversity of H9N2 Viruses Isolated from Wild Birds and Chickens in Hunan Province, China.

Three H9N2 avian influenza viruses were isolated from the Dongting Lake wetland, among which one was from fresh egret feces, the other two were from chicken cloacal swabs in poultry markets. Phylogene...

Medical and Biotech [MESH] Definitions

None available.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Public Health
Latest News Clinical Trials Research Drugs Reports Corporate
Public health is the scientific, political and sociological approach by a society to maximise the health of the population through disease preventaion and mainenance of healthy life-styles. The mains areas of public health are epidemiology, biostatistics...

Advertisement
review and buy H7N9 Bird Flu Virus market research data and corporate reports here

Channels Quicklinks